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Abstract 
Objective: We reviewed retrospectively the perioperative treatment of microsurgically resected brain arteriovenous 
malformations (bAVMs) at the neurosurgical department of Helsinki University Hospital between the years 2006 and 
2014. We examined the performance of the treatment protocol and the incidence of delayed postoperative hemor-
rhage (DPH).
Methods: The Helsinki protocol for postoperative treatment of bAVMs was used for the whole patient cohort of 121. 
The patients who had subsequent DPH were reviewed in more detail.
Results: Five out of 121 (4.1%) patients had DPH. These patients had a higher Spetzler–Martin grade (SMG) 
(p = 0.043) and a more complex venous drainage pattern (p = 0.003) as compared to those who had no postoperative 
bleed. Patients with DPH had 43% larger intravenous fluid intake in the neurosurgical intensive care unit (p = 0.052); 
they were all male (p = 0.040) and had longer stay in the intensive care unit (p = 0.022).
Conclusions: The Helsinki protocol for postoperative treatment of bAVMs was found to produce comparable results 
to a more complex treatment algorithm. DPH was associated with high SMG, complex venous drainage pattern, male 
gender and high intravenous fluid intake. Our findings support the use of SMG in defining patient’s postoperative 
treatment as the DPHs in our study occurred in patients with grade 2–5.
Keywords: Intracranial arteriovenous malformations, Neurosurgical intensive care unit, Postoperative hemorrhage, 
Retrospective study, Blood pressure, Clinical protocols
Introduction
Brain arteriovenous malformations (bAVMs) are a 
known cause of intracranial hemorrhage. BAVMs are 
found either incidentally (2–10%) or due to sympto-
matic presentation. BAVM may present with headache 
(6–14%), symptomatic epilepsy (18–35%) or a focal neu-
rological deficit (3–10%). However, hemorrhagic stroke 
is the most common presentation for a bAVM (45–72%) 
[1]. Microsurgical resection is the current treatment 
option for bAVMs, alongside with observation, radio-
surgery or endovascular treatment. Microsurgery is 
indicated if the operation is technically feasible, and the 
risks at an acceptable level [2–4]. The most feared com-
plication of bAVM surgery is delayed postoperative hem-
orrhage (DPH). The incidence of DPH ranges from 2 to 
21% depending on the study [5–11]. The Spetzler–Mar-
tin grading (SMG) system is used to evaluate the risk of 
surgical treatment of bAVMs. Grading is based on the 
size of the nidus, the eloquence of adjacent brain and the 
venous drainage of the nidus, with higher grade indicat-
ing greater risk for complications, such as DPH [12].
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The lack of a normal capillary network creates a shunt 
allowing abnormal blood flow from the arterial side to 
the venous side. This leads to a high-pressure environ-
ment in the venous side with risk of hemorrhage, if the 
vein tears. Redistribution of the blood flow following the 
removal of the bAVM may cause the surrounding brain 
parenchyma to swell and increase the risk of DPH. This 
may be explained with the normal perfusion pressure 
breakthrough hypothesis [13]. However, the underlying 
pathophysiology of edema and hemorrhage after bAVM 
resection remains controversial. Tight postoperative 
blood pressure control and a restrictive intravenous fluid 
management regime are used to decrease the risk of DPH 
[14–17].
Successful surgical treatment of bAVMs requires good 
microsurgical skills and anesthesiologic expertise. The 
basic treatment principles regarding microsurgery and 
neuroanesthesia at our department have been published 
previously. These guidelines aim at simple and fast opera-
tions preserving normal anatomy and maintaining stable 
hemodynamics while securing adequate cerebral perfu-
sion [18, 19]. The aim of this study was to investigate the 
incidence of DPH following surgical excision of bAVMs 
when the Helsinki protocol for the perioperative treat-
ment was used and to compare it to a comparable, albeit 
more complex, treatment protocol published by Morgan 
et al. [11].
Materials and Methods
After approval from Helsinki University Hospital Sci-
entific and Ethical Board, we retrospectively reviewed 
the hospital records of the patients who had under-
gone surgery for bAVM in the neurosurgical depart-
ment of Helsinki University Hospital between the years 
2006 and 2014. For this type of study, formal consent is 
not required. We collected data from the Helsinki AVM 
database, surgical and intensive care unit database and 
patient medical records.
The collected variables included age, sex, bAVM size 
and location, SMG, preoperative embolization, treatment 
related data during neurointensive care unit (NICU) stay 
(daily target systolic blood pressure [SBP], daily achieved 
SBP, daily fluid intake and output from the first postoper-
ative day (POD) onward, daily maximum and minimum 
central venous pressure, length of time spent in ventila-
tor), length of NICU stay and neurological outcome at 
2–4  months from surgery and incidence of DPH. Daily 
SBP target was achieved if SBP did not exceed the limit 
at all during the day. The Glasgow Outcome Scale (GOS) 
was determined by the treating neurosurgeon at the first 
follow-up visit and retrieved from the patient medical 
records.
DPH was defined as brain hemorrhage into the resec-
tion bed or brain parenchyma that was not evident in 
postoperative imaging and resulted in a need for reopera-
tion or a new neurological deficit, which occurred prior 
to discharge from the hospital. The same definition was 
used by Morgan et al. in their study [11].
Helsinki Protocol for Postoperative Treatment of bAVMs
All patients at the neurosurgical department of Helsinki 
University hospital treated for bAVMs follow the same 
postoperative treatment protocol according to the SMG. 
We describe the protocol in the following paragraphs and 
in Table 1.
For postoperative treatment, patients are divided to 
three groups, based on the AVM characteristics and sur-
gical complications (SMG and whether or not the AVM 
had ruptured preoperatively) (Table 1).
The patients in all three groups are taken back into sur-
gery for reoperation if postoperative angiography shows 
that the AVM has not been completely extirpated. If, 
however, the computed tomography (CT) scan shows 
hemorrhage or edema, the patient is kept hypotensive 
and sedated under controlled ventilation. If the imaging 
shows that a non-AVM related artery is obstructed, the 
blood pressure is increased up to 130–150 mmHg.
Postoperatively antiepileptic medication is given to 
all patients with supratentorial AVMs. Furthermore, if 
embolized preoperatively, glucocorticoid (betamethasone 
or dexamethasone) is started. For prevention of deep 
venous thrombosis, antiembolic stockings or venous 
pumps are used for the first postoperative week instead 
of pharmacological treatment because of increased risk 
of hemorrhage.
According to the Helsinki protocol, good collaboration 
between neuroradiologist, neurosurgeon and neuroanes-
thesiologist is essential when deciding the postoperative 
treatment [20].
Statistical Analysis
Statistical analysis was performed using IBM SPSS Sta-
tistics (version 24, IBM Corporation) program. Com-
parisons between variables were performed using 
Mann–Whitney U test, Pearson χ2, and Welch’s t test 
(variances tested with Levene’s test) as appropriate with 
SPSS. A statistical significance level of 5% was used for all 
analysis.
Results
Five patients out of 121 (4.1%) were identified with DPH 
after neurosurgical treatment of bAVM. When divided 
according to SMG, the incidence for DPH increases 
from grade 1 to 5: 0%, 2.7%, 2.9%, 11% and 17% (Fig. 1), 
respectively, p = 0.043 (Table  2). Deep venous drainage 
was related to DPH (p = 0.003) (Table 2). No patient with 
purely cortical venous drainage suffered from DPH. Four 
patients who had DPH had both cortical and deep and 
one had purely deep venous drainage (Table  2). All the 
patients with DPH were male and over 18 years of age at 
the time of operation. Relationship between gender and 
DPH was statistically significant with p = 0.040 (Table 2).
The median bAVM size in patients who did not have 
DPH was 20 mm (mean 26 mm), while in patients with 
DPH the median bAVM size was 35 mm (mean 45 mm) 
(Table  3). The postoperatively bled bAVMs were of 16, 
27, 35, 65 and 80  mm in diameter. The bAVM size did 
not correlate with incidence of DPH, p = 0.076 (Table 3). 
Patients with DPH had higher average daily intravenous 
fluid intake (3256  ml) during NICU stay compared to 
patients without DPH (2272 ml), a 43% relative increase, 
p = 0.052 (Table  4). NICU stay was longer in patients 
with DPH (p = 0.022). There was no difference in GOS 
at 2–4 months after operation between patients with or 
without DPH, p = 0.278. Patients with DPH had higher 
median SMG (4) than patients without (2). Succession 
rate in achieving all set SBP targets was achieved with 
49% of the patients and was similar between patients with 
or without DPH (p = 0.689). Only five patients failed SBP 
target every day and none of them had DPH (Table 2). 
Case Studies of Patients with DPH
Case 1
Fifty-two-year-old male was included, a smoker with 
hypertension and alcoholism. Imaging after epileptic sei-
zure revealed a previously unruptured bAVM of 35 mm 
diameter (SMG 4) at the left Sylvian fissure. Preoperative 
embolization was not feasible.
The patient was operated on via a frontotemporal cra-
niotomy. Large anteromedial draining vein ruptured 
intraoperatively but was successfully coagulated. Both 
M2 branches were temporarily clipped. Good hemosta-
sis was achieved, and postoperative angiography showed 
complete removal of the AVM.
First POD CT-scan showed some hemorrhage around 
the operative area. SBP target was kept under 120 mmHg 
until raised to 140 mmHg on the third POD. At the sixth 
POD, CT-scan showed large hematoma in the tempo-
ral lobe. The hematoma was evacuated. The suspected 
source of bleeding was a small artery adjacent to the 
operative area.
Next day, CT-scan showed a new hematoma. Angiog-
raphy found the source to be a flow related M1 aneurysm 
which was operated on the same day. Tracheostomy was 
performed on the 12th POD with SBP target of under 
150  mmHg. On the 22nd POD, the patient was sent to 
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the neurosurgical ward, on the 34th to local hospital. 
GOS at 5 months was 3.
Case 2
Twenty-year-old male with psychiatric history was diag-
nosed with a preoperatively ruptured SMG 4 bAVM of 
65  mm in the right temporal lobe after presenting with 
intracranial and intraventricular hemorrhage.
The operation was performed via a frontotemporal pte-
rional craniotomy. Major (1350 ml) intraoperative bleed-
ing occurred during nidus dissection. Bleeding continued 
until the complete removal of the nidus. Intraoperative 
angiography showed no residual AVM. Postoperative 
SBP target was 90–120 mmHg.
CT-angiogram on the first POD showed early fill-
ing of a cortical vein. CT-scan showed small subdural 
hematoma and operative site hematoma, which did not 
require evacuation. The patient was extubated on the 2nd 
POD. On the 9th POD, the patient was transferred to a 
regional hospital where he soon developed a severe head-
ache. CT-scan showed epidural blood collection around 
craniotomy area. The patient was transferred back to the 
neurosurgical unit where 30  ml of blood was aspirated 
with a needle on arrival, easing the headache and then 
recraniotomy was performed to evacuate the epidural 
hematoma. A small cortical lesion was seen under the 
dura and promptly coagulated. Epidural drain was left for 
48 h postoperatively. CT-scan showed significant residual 
hematoma and air around the operative area. On the 4th 
day after recraniotomy, the patient was sent back to the 
regional hospital. GOS at 3 months was 5.
Case 3
Fifty-two-year-old, otherwise, healthy male was diag-
nosed with a ruptured 16-mm left-sided temporo-occip-
ital AVM of SMG 3 after an epileptic seizure. The AVM 
was embolized twice with Onyx 6  months before the 
operation with partial occlusion of the nidus. The opera-
tion was performed via parieto-occipital craniotomy.
Digital subtraction angiography (DSA) on first POD 
showed complete removal of the nidus. Retrograde filling 
was perceived from small branches near the AVM bed. 
On the 4th POD, the patient had right-sided convulsions, 
dysphasia and headache. CT-scan showed intraventricu-
lar hemorrhage from the AVM site and hydrocephalus. 
A right-sided ventriculostomy was inserted. On the 8th 
POD, meningitis was diagnosed, and antimicrobial treat-
ment started. The ventriculostomy was removed on the 
10th POD. On the 13th POD, the patient was sent back 
to his local university hospital for further recovery with 
GOS 4.
Case 4
A forty-seven-year-old man was diagnosed with a pre-
operatively ruptured large right-sided temporal AVM 
(diameter 80 mm, SMG 5). The AVM was first diagnosed 
and embolized after bleeding at the age of 20. Further 
treatment included embolization and proton therapy. 
Fig. 1 DPH by Spetzler–Martin grade
Table 2 Characteristics of the study
Was there delayed postopera-
tive hemorrhage
No Yes p=
Spetzler–Martin 1 Sex Female 13 0
Male 12 0
Total 25 0
All daily SBP targets achieved No 10 0
Yes 15 0
Total 25 0
2 Sex Female 14 0
Male 22 1
Total 36 1
All daily SBP targets achieved No 20 1
Yes 16 0
Total 36 1
3 Sex Female 17 0
Male 17 1
Total 34 1
All daily SBP targets achieved No 20 0
Yes 14 1
Total 34 1
4 Sex Female 6 0
Male 10 2
Total 16 2
All daily SBP targets achieved No 8 1
Yes 8 1
Total 16 2
5 Sex Female 4 0
Male 1 1
Total 5 1
All daily SBP targets achieved No 1 1
Yes 4 0
Total 5 1
Total Sex Female 54 0
Male 62 5
Total 116 5 ,040a
All daily SBP targets achieved No 59 3
Yes 57 2
Total 116 5 ,689a
Any daily SBP targets achieved No 5 0
Yes 111 5
Total 116 5 ,635a
Spetzler–Martin 116 5 ,043b
Mean age on admission (years) (SD) 42,26 (18,37) 46,53 (15,32) ,574c
Was embolization performed before 
surgical excision
No 77 3
Yes 36 1
,772a
Associated aneurysm, yes/no No 80 3
Yes 26 1
Total 106 4 ,983a
After the patient started to suffer from severe headache, 
hallucinations and vertigo, CT-scan was performed 
showing a small intraventricular hemorrhage.
The surgery was done via right-sided temporal crani-
otomy. The AVM was attached to the dura at multiple 
sites. Multiple temporary clips were placed on the feed-
ing arteries during the operation. Intraoperative angiog-
raphy showed filling also from the posterior circulation. 
The AVM started filling quickly from deep basal arteries 
after it was thought to be dissected successfully. These 
were coagulated and the nidus removed. Some occipital 
residual AVM was visualized and removed. There was 
some hemorrhage during clip removal which was coagu-
lated. Blood loss during surgery was 300 ml.
The postoperative SBP target was 100–130 mmHg. CT-
scan and DSA showed no complications at 1st POD. On 
the 3rd POD, CT-scan showed blood in subdural space, 
resection cavity and subcutaneously. Cerebrospinal fluid 
(CSF) analysis on the 3rd POD showed potential infec-
tion and vancomycin and ceftazidime were started. The 
patient was extubated on the 4th POD, but reintubated 
due to worsening general status on the 5th POD. The 
SBP target was set to normotension on the 5th POD. 
The patient was extubated on the 7th POD. The patient 
was transferred to city hospital on the 29th POD. GOS at 
the first follow-up was 3. The patient initially developed 
right-sided ptosis which resolved by itself but was blind 
in his right eye at first follow-up visit due to uncertain 
Table 2 (continued)
Was there delayed postopera-
tive hemorrhage
No Yes p=
Venous drainage Cortical 69 0
Deep 17 1
Cortical and deep 25 4
Total 111 5,00 ,003b
Venous drainage Cortical Mean AVM size in mm (Angiography or 
CT largest diameter) (SD)
24 (14)
Deep Mean AVM size in mm (Angiography or 
CT largest diameter) (SD)
18 (10) 16 (–)
Cortical and deep Mean AVM size in mm (Angiography or 
CT largest diameter) (SD)
40 (21) 52 (25)
Outcome at 2–4 mos (1. follow-up); GOS Good recovery 53 1
Moderate disability 29 1
Severe disability 19 3
Vegetative state 0 0
Dead 6 0
Not known 9 0
Total 116 5 ,278b
AVM arteriovenous malformation, CT computed tomography, GOS Glasgow Outcome Scale, SBP systolic blood pressure, SD standard deviation
a Pearson Chi-square
b Independent samples Mann–Whitney U test
c Welch’s t test
Table 3 AVM size and DPH
AVM arteriovenous malformation, CT computed tomography, IR interquartile 
range, SD standard deviation
a Independent samples Mann–Whitney U test
AVM size in mm 
(Angiography or CT 
largest diameter)
Was there delayed post-
operative hemorrhage
No Mean (SD) 26 (17)
Median (IR) 20 (23)
Maximum 88
Minimum 5
Yes Mean (SD) 45 (27)
Median (IR) 35 (51)
Maximum 80
Minimum 16
p= ,076a
Total Mean (SD) 27 (18)
Median (IR) 20 (23)
Maximum 88
Minimum 5
Table 4 Daily IV fluid intake in  milliliters, operating physician (A = experienced attending neurosurgeon) and  average 
NICU unit stay length in days by Spetzler–Martin grade and incidence of DPH
DPH delayed postoperative hemorrhage, IV intravenous, NICU neurointensive care unit, SD standard deviation
a Pearson Chi-square
b Welch’s t test
Was there delayed postoperative hemorrhage
No Yes p= Total
Spetzler–Martin 1 Operating physician A 19 0 19
Other 6 0 6
Total 25 0 25
Mean daily IV fluid intake (ml) (SD) 1824,97 (1347,23) 1824,97 (1347,23)
Mean NICU days (SD) 4 (3) 4 (3)
Mean time in days between intubation and extuba-
tion (SD)
4 (8) 4 (8)
2 Operating physician A 28 1 29
Other 8 0 8
Total 36 1 37
Mean daily IV fluid intake (ml) (SD) 2251,16 (1269,99) 4310,40 2317,59 (1302,27)
Mean NICU days (SD) 5 (4) 22 5 (5)
Mean time in days between intubation and extuba-
tion (SD)
3 (5) 3 (5)
3 Operating physician A 27 1 28
Other 7 0 7
Total 34 1 35
Mean daily IV fluid intake (ml) (SD) 2639,47 (1098,67) 2499,00 2634,79 (700,31)
Mean NICU days (SD) 5 (5) 11 6 (5)
Mean time in days between intubation and extuba-
tion (SD)
5 (8) 1 5 (8)
4 Operating physician A 14 2 16
Other 2 0 2
Total 16 2 18
Mean daily IV fluid intake (ml) (SD) 2244,79 (1370,89) 3168,15 (994,40) 2347,38 (1343,71)
Mean NICU days (SD) 8 (7) 16 9 (7)
Mean time in days between intubation and extuba-
tion (SD)
5 (8) 3 5 (8)
5 Operating physician A 5 1 6
Other 0 0 0
Total 5 1 6
Mean daily IV fluid intake (ml) (SD) 2313,76 (1625,19) 3133,10 2450,32 (1491,60)
Mean NICU days (SD) 6 (4) 11 7 (4)
Mean time in days between intubation and extuba-
tion (SD)
3 (2) 8 4 (3)
Total Operating physician A 93 5 98
Other 23 0 23
Total 116 5 ,269a 121
Mean daily IV fluid intake (ml) (SD) 2271,71 (1281,20) 3255,76 (822,22) ,052b 2317,69 (1277,93)
Mean NICU days (SD) 5 (5) 15 ,022b 6 (5)
Mean time in days between intubation and extuba-
tion (SD)
4 (7) 4 ,954b 4 (7)
etiology. The patient was deemed receptive for occupa-
tional and physiotherapy.
Case 5
Sixty-year-old otherwise healthy male was admitted to 
the hospital 9 days prior to surgery because of explosive 
headache. Similar but less intense headache had occurred 
3 months earlier. Imaging studies revealed subarachnoid 
and intraventricular hemorrhage caused by a previously 
ruptured left-sided frontal bAVM (diameter 27  mm, 
SMG 2) fed by the anterior cerebral artery (ACA). Four 
days prior to surgery, the patient became disoriented due 
to hydrocephalus and a ventriculostomy was placed.
The operation was performed via a paramedian fron-
toparietal craniotomy. Hemosiderin was found con-
firming the earlier bleeding. Pericallosal arteries were 
temporarily clipped anteriorly to the nidus during AVM 
dissection, and the nidus was removed. Due to the fra-
gility of feeding arteries, postoperative SBP target was 
less than 100 mmHg; however, during closure, there was 
a peak in SBP up to 160  mmHg. Immediate postopera-
tive imaging showed removal of the AVM and hematoma 
anterior to the resection cavity.
On the 1st POD, CT-scan showed increase in the 
hematoma size. SBP target was raised on the 2nd POD to 
under 120 mmHg. On the 3rd POD, the size of patient’s 
left pupil varied, but CT-scan showed no change in the 
hematoma size. EEG showed a possible epilepsy focus. 
Right-sided ventriculostomy was inserted which pro-
duced 20  ml of bloody CSF with high pressure. By the 
4th POD, the drain had produced 95 ml of liquor over 15 
cm  H2O valve pressure. CT-scan confirmed good place-
ment of the drain and good demarcation on the infarcts 
on both ACA supply areas. SBP upper limit was raised to 
130 mmHg and the following day to 140 mmHg.
On the 7th POD, the SBP target was raised to less 
than 150 mmHg and a tracheostomy was performed. On 
the 10th POD, the sedation was eased, and the patient 
resumed spontaneous breathing. On the 14th POD, the 
patient was still ventriculostomy dependent and trans-
ferred to his local university hospital. MRI showed no 
improvement, and best neurological response was flexion 
with left-sided hemiparesis. GOS at 18 months was 3.
Discussion
Helsinki protocol for postoperative treatment of bAVMs 
was applied in all patients in this study. Five out of 121 
patients (4.1%) developed DPH. Incidence of DPH in our 
study is in line with incidence of DPH (4.4% after proto-
col implementation) in an earlier larger study by Morgan 
et al. [11] in which patients also followed targeted albeit 
a more complicated postoperative treatment protocol. 
There are great variations in the reported incidences of 
DPH (2–21%), some of which may be explained by differ-
ent definition of DPH between the studies [5–10].
The risk for developing DPH following surgical resec-
tion is considerable, yet the benefit from complete cure 
from future bAVM-related hemorrhage is noteworthy. 
The risk for DPH is significantly higher when the SMG of 
the bAVM is 3 or higher. Smaller bAVMs with low SMG 
have very negligible risk for developing DPH.
Our postoperative treatment protocol and the one 
described by Morgan et  al. for bAVMs are similar. The 
main difference is the simplicity of our protocol making 
its implementation easier for treatment personnel with 
less chance for error-related adverse effects. The periop-
erative treatment protocol used by Morgan et al. [11, 14] 
has been described in detail in earlier studies.
The Helsinki protocol used for all the patients in this 
study focuses on patients’ blood pressure and intrave-
nous fluid regimen. For large AVMs, SBP is kept low for 
several days avoiding any peaks in blood pressure. Pro-
tocol published by Morgan et al. uses both mean arterial 
blood pressure (MAP) and cerebral perfusion pressure 
(CPP) for hemodynamic control in patients with SMG 
3–5. Their target is to keep MAP under 70  mmHg and 
CPP over 60  mmHg or at over 50  mmHg with barbitu-
rate induced coma, which leaves a very small window 
for intracranial and blood pressure levels. Barbiturate 
induced coma was not used in our protocol at all. Instead, 
propofol and dexmedetomidine were used for sedation 
postoperatively. Propofol was gradually changed to dex-
medetomidine before extubation. Our protocol divided 
the patients into three groups taking into account the 
SMG and surgical treatment, whereas our colleagues 
divided their patient population to three groups based 
on SMG and bAVM diameter. The use of glucocorti-
coids was more limited in our study. Only those patients 
who were preoperatively embolized were started on 
betamethasone depending on the clinician’s judgment, 
whereas our colleagues’ protocol started all patients pre-
operatively on dexamethasone.
Deciding a proper perioperative treatment protocol for 
each patient is a very important decision. The more com-
plex protocol presented by Morgan et al. would seem to 
work quite well for patients at high risk for DPH (Spetzler 
Ponce class C in their study), but as shown in our study a 
simpler protocol might be as appropriate. Patients with 
small risk for developing DPH may not benefit from such 
interventional and invasive treatment. Moreover, a less 
aggressive treatment protocol may shorten the NICU 
stay and reduce treatment related adverse events such as 
infections and also the cost of the treatment [21, 22].
The average NICU stay length for patients with DPH 
was 15 days and 5 for those without (6 days for the whole 
cohort), whereas the only reported length of NICU stay 
by Morgan et al. was for Spetzler–Ponce class C bAVMs 
being minimum of 7 days.
The use of induced barbiturate coma as a postoperative 
treatment therapy is not part of our protocol but was of 
considerable importance to the protocol introduced by 
Morgan et al. [11]. Induced barbiturate coma effectively 
decreases intracranial pressure. It has, however, notable 
adverse effects, including negative long-term cognitive 
effects [23, 24].
Morgan et al. [11] speculated that neurosurgeons skill 
development was a limiting factor in their study. In our 
study, most of the patients were operated by the same 
neurosurgeon with vast experience in bAVM surgery 
already from the beginning of the study.
Comparison of Patients Who Developed DPH with Those 
Who Did Not
All the patients who developed DPH were male. Although 
statistically significant, reason for that might purely be 
the low number of DPHs. Males often have higher blood 
pressure than females throughout their lives, and hyper-
tension is a major risk factor for DPH [25, 26]. However, 
female gender is associated with increased risk for sub-
sequent hemorrhage for non-treated AVMs [27]. Females 
might be more suited for surgical treatment, if their risk 
for DPH is lower and bAVM hemorrhage higher.
The average daily intravenous fluid intake during 
NICU was 43% higher with patients who had DPH with 
p = 0.052, which borders on statistical significance. 
This affirms our protocols focus on strict fluid control, 
although a larger study population would be needed to 
confirm the possible effect fluid load has on incidence of 
DPH.
All daily SBP targets were achieved with about half the 
patients. Low achievement rate is partly explained by the 
strict interpretation. All SBP targets were failed in only 
five patients, none of whom developed DPH.
Discussion of the Presented Patient Case Studies with DPH
We thoroughly reviewed the patients who had DPH to 
find out if choosing another treatment protocol would 
have prevented DPH. Case 1 had DPH on 6th POD even 
though a strict blood pressure control had been followed. 
This reinforces the understanding that redistribution of 
blood flow exposes brain parenchyma to great pressure 
possibly leading to bleeding. Smoking, hypertension and 
alcoholism may have contributed to the outcome.
Major intraoperative hemorrhage and large bAVM 
increased the risk of developing DPH for the second case 
and led to a very strict postoperative blood pressure con-
trol. One might consider whether the epidural hematoma 
should have been evacuated earlier or not. Probably, the 
hematoma was more related to the craniotomy than the 
AVM itself. Nevertheless, the patient was young and had 
an excellent recovery regardless of DPH.
The third case developed DPH on 4th POD. The 
patient was otherwise healthy aside from his bAVM 
and had moderate disability on the GOS at first follow-
up. His outcome might have been better had he had his 
bAVM surgically excised without preoperative partial 
embolization altering the hemodynamic profile of the 
nidus.
The fourth patient was evaluated to have a high risk of 
postoperative complications. Strict protocol was applied. 
Bleeding in surgical cavity was thought to be related to 
surgery itself as there was no intraparenchymal compo-
nent. In review, we do not believe that by treating the 
patient differently, we could have improved the outcome. 
The surgical risk for such complicated and large bAVMs 
is very high.
The fifth case is the most interesting in relation to the 
treatment protocol. Although the SMG was 2 and the 
bAVM small, a strict postoperative protocol was applied 
due to the preoperative bleeding and intraoperative find-
ings. The operation was uneventful aside from the one 
blood pressure spike to 160 mmHg during closure. This 
blood pressure spike was the presumed cause of the DPH 
that was visualized on postoperative imaging. The conse-
quences of one blood pressure spike during the operation 
emphasize the need for careful blood pressure manage-
ment throughout the perioperative period.
The five patients who developed DPH show that how-
ever hard we try to control the risk factors for DPH, we 
are unable to completely prevent them from happening. 
The pathophysiology of bAVMs brings with it an inherent 
risk for DPH. We have used fluid restriction and hypo-
tension to try to control the hemodynamic stress result-
ing from removal of the bAVM. Hypervolemia leads to 
increased hydrostatic pressure in the fragile capillary bed 
surrounding the AVM and in our opinion might cause 
edema, but scarcely hemorrhage. We do not believe the 
benefits from an even stricter fluid regimen would out-
weigh the adverse effects, especially since the incidence 
of DPH in our series is already comparable to the previ-
ously published series with a more strict protocol.
Limitations of the Study
The cohort size of the study was small and the incidence 
of DPH rare. With only five incidents of DPH out of 121 
participants in the study high level of statistical power are 
not achieved.
As our study was retrospective, we have no control 
group. Further study is required to produce more rig-
orous evidence on postoperative bAVM treatment 
protocols. However, bAVMs are a very rare disease, and 
their most feared complication, DPH, an uncommon 
complication.
Conclusion
DPH was associated with high SMG, which supports its 
use in deciding postoperative treatment, complex venous 
drainage pattern, male gender and high intravenous fluid 
intake. Helsinki protocol for postoperative treatment of 
bAVMs seems to perform equally well when compared 
to a more complicated protocol. The benefits of simpler 
protocols are multifarious such as making the implemen-
tation of the protocol easier, decreasing the chance for 
treatment personnel error and reducing the risk for treat-
ment related adverse event. Further study with greater 
study size would be required to produce more rigorous 
evidence for postoperative treatment of microsurgically 
resected bAVMs; however, thus far Helsinki protocol 
seems to perform adequately.
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